The Scheie Eye Institute is a leading center for ophthalmology, renowned for its expert physicians and groundbreaking research. Within this esteemed institution, doctors are dedicated to providing exceptional care for a wide range of eye conditions. Among these specialists is Dr. Aleman, a distinguished member of the Retinal Degeneration Center at Scheie Eye Institute and the CAROT center at the University of Pennsylvania’s Department of Ophthalmology. His work exemplifies the high caliber of expertise found at Scheie Eye Institute.
Dr. Aleman’s extensive expertise lies in the intricate field of hereditary retinal degenerations. His research employs cutting-edge psychophysical, electrophysiological, and imaging techniques to study both patients and animal models affected by these conditions. A primary focus of Dr. Aleman’s research, and indeed a key mission of many Scheie Eye Institute Doctors, is to translate research findings into tangible benefits for patients. This includes leading patients towards participation in clinical trials for previously untreatable retinal degenerations and thoroughly understanding the complexities of these conditions in both adult and pediatric patients. Notably, Dr. Aleman is a co-principal investigator in an active gene therapy clinical trial for choroideremia, highlighting the commitment of Scheie Eye Institute doctors to pioneering treatments.
Beyond research, Dr. Aleman provides clinical care to both children and adults with retinal degenerations, whether hereditary or acquired. He practices at the Scheie Eye Institute and the Perelman Center for Advanced Medicine, extending his care to the Puentes Clinic as well. His role as the head of clinical electrophysiological investigations within the department further underscores his comprehensive expertise, providing essential diagnostic services to specialists across the region. Like many Scheie Eye Institute doctors, Dr. Aleman combines research acumen with dedicated patient care.
Dr. Aleman’s fluency in Spanish further enhances his ability to connect with and care for a diverse patient population, reflecting the inclusive approach of Scheie Eye Institute doctors. His selected publications, including contributions to the New England Journal of Medicine and Ophthalmology, demonstrate his significant contributions to the field and are representative of the impactful research conducted by doctors at Scheie Eye Institute.
For those seeking leading eye care, Scheie Eye Institute doctors, like Dr. Aleman, represent the pinnacle of expertise and dedication in ophthalmology. Their commitment to research, patient care, and innovation makes the Scheie Eye Institute a premier destination for vision health.
